Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-08-006467
Filing Date
2008-11-06
Accepted
2008-11-06 20:48:16
Documents
2
Period of Report
2008-10-28

Document Format Files

Seq Description Document Type Size
1 c55565_ex.html 3  
1 c55565_ex.xml 3 7507
2 c55565_ex99-1.htm EX-99.1 5885
  Complete submission text file 0000930413-08-006467.txt   15172
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /DE/ (Issuer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: DE | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WHEATON CAPITAL MANAGEMENT LLC 13 LUCILLE CT. EDISON NJ 08820
Business Address 7323215145
TREPPEL JERRY (Reporting) CIK: 0001213711 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15697 | Film No.: 081168575